-
K413526-10mgInformationKDU691 KDU691 is a Plasmodium PI4K -specific inhibitor with IC50 values of 0.18 μM and 0.061 μM against hypnozoite forms and liver schizontsm, respectively.TargetsPI4K.
-
K413526-25mgInformationKDU691 KDU691 is a Plasmodium PI4K -specific inhibitor with IC50 values of 0.18 μM and 0.061 μM against hypnozoite forms and liver schizontsm, respectively.TargetsPI4K.
-
K413526-2mgInformationKDU691 KDU691 is a Plasmodium PI4K -specific inhibitor with IC50 values of 0.18 μM and 0.061 μM against hypnozoite forms and liver schizontsm, respectively.TargetsPI4K.
-
K413526-50mgInformationKDU691 KDU691 is a Plasmodium PI4K -specific inhibitor with IC50 values of 0.18 μM and 0.061 μM against hypnozoite forms and liver schizontsm, respectively.TargetsPI4K.
-
K413526-5mgInformationKDU691 KDU691 is a Plasmodium PI4K -specific inhibitor with IC50 values of 0.18 μM and 0.061 μM against hypnozoite forms and liver schizontsm, respectively.TargetsPI4K.
-
K421794-1mlInformationKDU691 KDU691 is a Plasmodium PI4K -specific inhibitor with IC50 values of 0.18 μM and 0.061 μM against hypnozoite forms and liver schizontsm, respectively.TargetsPI4K.
-
K287947-10mgKH7 has been used: as a soluble adenyl cyclase (sAC) antagonist to study its effect on the signaling pathway mediated by the action of transient receptor type 1 (TRPV1) in sperm cells. as a selective sAC antagonist to study its effect on the
-
K287947-250mgKH7 has been used: as a soluble adenyl cyclase (sAC) antagonist to study its effect on the signaling pathway mediated by the action of transient receptor type 1 (TRPV1) in sperm cells. as a selective sAC antagonist to study its effect on the
-
K287947-50mgKH7 has been used: as a soluble adenyl cyclase (sAC) antagonist to study its effect on the signaling pathway mediated by the action of transient receptor type 1 (TRPV1) in sperm cells. as a selective sAC antagonist to study its effect on the
-
-
-
L648554-10mgLaetanine, a noraporphine alkaloid from Litsea laeta , exhibits antiplasmodial activity.Form:Solid.